ImportRefusal LogoImportRefusal

Ocs A Div Of Pyramid

⚠️ High Risk

FEI: 3003275679 • Kempton Park, Gauteng • SOUTH AFRICA

FEI

FEI Number

3003275679

📍

Location

Kempton Park, Gauteng

🇿🇦
🏢

Address

120 Loper Avenue, , Kempton Park, Gauteng, South Africa

High Risk

FDA Import Risk Assessment

56.3
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

26
Total Refusals
3
Unique Violations
3/3/2005
Latest Refusal
3/21/2002
Earliest Refusal

Score Breakdown

Violation Severity
78.8×40%
Refusal Volume
53.0×30%
Recency
0.0×20%
Frequency
88.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7517×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1798×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

2181×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

Refusal History

DateProductViolationsDivision
3/3/2005
65MCP99PROTHYROTROPIN N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
7/2/2003
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/12/2003
54FDH99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
218LIST INGRE
New Orleans District Office (NOL-DO)
7/3/2002
62QBB99ANTI-RHEUMATIC N.E.C.
179AGR RX
New Orleans District Office (NOL-DO)
6/13/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
179AGR RX
New Orleans District Office (NOL-DO)
3/25/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
179AGR RX
New Orleans District Office (NOL-DO)
3/25/2002
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/25/2002
61JCA08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/23/2002
61JCA08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/23/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/23/2002
61JCA08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/23/2002
61JCA08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/23/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/22/2002
61NDY99ANTI-DEPRESSANT N.E.C.
179AGR RX
New Orleans District Office (NOL-DO)
3/22/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/22/2002
61JCA08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/22/2002
61JCA08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/22/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/22/2002
60LCA83CELECOXIB (ANALGESIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/22/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/22/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/22/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/21/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
179AGR RX
New Orleans District Office (NOL-DO)
3/21/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
179AGR RX
New Orleans District Office (NOL-DO)
3/21/2002
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
179AGR RX
New Orleans District Office (NOL-DO)
3/21/2002
66VCP99MISCELLANEOUS PATENT MEDICINES, ETC.
179AGR RX
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Ocs A Div Of Pyramid's FDA import refusal history?

Ocs A Div Of Pyramid (FEI: 3003275679) has 26 FDA import refusal record(s) in our database, spanning from 3/21/2002 to 3/3/2005.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Ocs A Div Of Pyramid's FEI number is 3003275679.

What types of violations has Ocs A Div Of Pyramid received?

Ocs A Div Of Pyramid has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Ocs A Div Of Pyramid come from?

All FDA import refusal data for Ocs A Div Of Pyramid is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.